Bone-kidney axis: A potential therapeutic target for diabetic nephropathy.

Shilu Luo, Jinfei Yang, Wei Chen, Liyu He, Di Liu, Li Zhao, Ming Yang, Xi Wang

Journal: Frontiers in endocrinology 2022;13():996776

PMID: 36353239

Abstract

Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD). However, its pathogenesis remains unclear, and effective prevention and treatment strategies are lacking. Recently, organ-to-organ communication has become a new focus of studies on pathogenesis. Various organs or tissues (the liver, muscle and adipose tissue) secrete a series of proteins or peptides to regulate the homeostasis of distal organs in an endocrine manner. Bone, an important part of the body, can also secrete bone-derived proteins or peptides that act on distal organs. As an organ with high metabolism, the kidney is responsible for signal and material exchange with other organs at any time through circulation. In this review, we briefly discussed bone composition and changes in bone structure and function in DN and summarized the current status of bone-derived proteins and their role in the progression of DN. We speculated that the "bone-kidney axis" is a potential target for early diagnosis and treatment of DN.

Copyright © 2022 Yang, Luo, Yang, Chen, He, Liu, Zhao and Wang.

Address: Department of Nutrition, Xiangya Hospital, Central South University, Changsha, China.; Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.; Department of Reproduction and Genetics, The First Affiliated Hospital of Kunming Medical University, Kunming, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.